Loading
Loading…
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹24.6 LQualified Make: Roche
Model: POLIVY® 30mg Inj.
Title: Polatuzumab Vedotin 30mg Inj ROOM NO 609 6TH FLOOR 32 EZRA STREET LALBAZAR KOLKATA WEST BENGAL 700001 | KOLKATA | WEST BENGAL | 700001 | Make: Roche
Model: POLIVY® 30mg Inj.
Title: Polatuzumab Vedotin 30mg Inj | L1 | Qualified MII |
Tender Value
Refer Docs
EMD Value
₹76,756
Closing Date
13 May 2025, 2:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Polatuzumab Vedotin 30mg Inj
7708239
GEM/2025/B/6111639
Two Packet Bid
Polatuzumab Vedotin 30mg Inj
30 days
Kolkata, West Bengal
Total value wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
2 yrs
₹3
20%
₹76,756
13 May 2025
22 Apr 2025
13 May 2025
Polatuzumab Vedotin 30mg Inj
Polatuzumab Vedotin 30mg Inj
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7708239.pdf
GEM_BID
origin890pdf_2025-04-04-10-32-36_7d8604e7b211a4d7a356acdaf3e77451.pdf
SPECIFICATION
Origin890_9172f8e4-3640-4ed7-a53b1743744980020_buyer11chec.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .